Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers

A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

ClinicalTrials.gov ID: NCT03815695

Public ClinicalTrials.gov record NCT03815695. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-controlled, Double Blind, Single Ascending and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

Study identification

NCT ID
NCT03815695
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Forma Therapeutics, Inc.
Industry
Enrollment
130 participants

Conditions and interventions

Interventions

  • FT-4202/Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 65 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 10, 2018
Primary completion
Dec 16, 2021
Completion
Dec 16, 2021
Last update posted
Apr 9, 2024

2018 – 2021

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
Woodland International Research Group (SCD subjects only) Little Rock Arkansas 72211
Collaborative Neuroscience Research, LLC (SCD subjects only) Long Beach California 90806
Pacific Research Partners (SCD subjects only) Oakland California 94607
UCSF Benioff Children's Hospital Oakland (SCD subjects only) Oakland California 94609
Advanced Pharma CR, LLC (SCD subjects only) Miami Florida 33147
Children's Healthcare of Atlanta (SCD subjects only) Atlanta Georgia 30342
Augusta University Medical Center (SCD subjects only) Augusta Georgia 30912
University of Illinois at Chicago (SCD subjects only) Chicago Illinois 60612
University of Maryland, Greenebaum Comprehensive Cancer Center (SCD subjects only) Baltimore Maryland 21201
Columbia University Medical Center (SCD subjects only) New York New York 10032
Levine Cancer Institute (SCD subjects only) Charlotte North Carolina 28204
Duke University Medical Center (SCD subjects only) Durham North Carolina 27710
University of Cincinnati Medical Center (SCD subjects only) Cincinnati Ohio 45219
Medpace Clinical Pharmacology Unit (Healthy Volunteers only) Cincinnati Ohio 45227
Cincinnati Children's Hospital Medical Center (SCD subjects only) Cincinnati Ohio 45229
Lynn Institute of Tulsa (SCD subjects only) Tulsa Oklahoma 74135
St. Jude Children's Research Hospital (SCD subjects only) Memphis Tennessee 38105
The University of Texas Health Science Center at Houston (SCD subjects only) Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03815695, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03815695 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →